Implementing a Guideline-based Model of Care for Hip and Knee Osteoarthritis in Finland. A Benchmarking-controlled Trial (FIN-OA)

NCT06904885 | Not Yet Recruiting

• 1 other identifier: 263/13.00.04.00/2025
• Study Type: observational
• Target: 10,000
• Locations: 0 countries
• Sites: N/A

Brief Summary

This project aims to bridge the gap between guideline recommendations and clinical practice in osteoarthritis (OA) management. By implementing a systematic, evidence-based model of care, the project seeks to improve patient outcomes, reduce healthcare costs, and provide equitable access to care. The project consists of three phases. In the first phase the current OA care is mapped through registry review and questionnaires and interviews of patients and healthcare professionals. In the second, implementation phase of the project, a plan will be created how to support healthcare professionals in delivering care according to the new model of care and training and support will be offered according to the plan. In the third phase of the project, the implementation success will be evaluated, and the costs of OA care evaluated and compared to baseline data. In addition, patient-reported data will be collected from those patients, who participate in the group-based exercise and education program.

Conditions

Osteoarthritis of the Hip or Knee

Keywords

osteoarthritis; implementation; benchmarking controlled trial; model of care; care pathway

Outcome Measures

Primary Outcomes (2)

• Cost of OA care

  Healthcare cost associated with the new care pathway incluing annual healthcare consultation prevalence, number and cost of hospitalizations, OA-related surgical interventions and primary and specialized healthcare and outpatient specialist visits. Filled prescriptions, number and duration of OA-related sick leaves and disability pensions. Costs will be analysed using data from national registers in pre and post implementation, both within the pilot Wellbeing Services Counties and between the pilot and other Wellbeing Services Counties.

  1 (primary endpoint), 3 and 5 years after implementation compared to baseline 2018-2024

• Reach: Proportion of patients directed according to the model of care

  Proportion of patients with hip and knee related symptoms and OA who contact healthcare that are referred to direct access physiotherapy and to GLA:D program

  1 (primary endpoint) 3 and 5 years after implementation

Secondary Outcomes (20)

• Number of trained GLA:D trainers and physiotherapists

  1, 3 and 5 years after implementation

• Participation of patients in GLA:D program

  1, 3 and 5 years after implementation

• Pain intensity during last week, numerical rating scale

  Baseline, 3 months, 1, 3 and 10 years

• Problems walking due to knee /hip

  Baseline, 3 months, 1, 3 and 10 years

• UCLA activity score

  Baseline, 3 months, 1, 3 and 10 years

Other Outcomes (16)

• The Determinants of Implementation Behaviour Questionnaire

  after delivering first GLA:D program and at 12 months

• Gender

  Baseline

• Age

  Baseline

Study Arms (4)

Patients participating GLA:D program

GLA:D -trained physiotherapists

Behavioral: Implementation of a guideline-based model of care for hip and knee osteoarthritis

Registry data from national registries (pre)

Data of people with hip or knee OA from national registries from all Wellbeing Services Counties in Finland before the implementation of new model of care.

Registry data from national registries (post)

Data of people with hip or knee OA from national registries from all Wellbeing Services Counties in Finland after the implementation of new model of care.

Interventions

Implementation of a guideline-based model of care for hip and knee osteoarthritis BEHAVIORAL

Guideline-based model of care including GLA:D (Good Life with osteoArthritis from Denmark) -program that includes training for physiotherapists and group based education and exercise for patients with hip and knee OA.

GLA:D -trained physiotherapists

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

National registry data: Patients with diagnosed OA from all Wellbeing Services Counties in Finland GLA:D patient-reported outcome data: Patients who are participating in the GLA:D program, diagnosed with hip or knee osteoarthritis in any location that delivers GLA:D program.

You may qualify if:

• Patients who are participating in theGLA:D program, diagnosed with hip or knee osteoarthritis, fluent in finnish
• age over 18 years

You may not qualify if:

• Other than OA-related cause of symptoms
• not able to answer the questionnaires in Finnish
• no access to a computer or mobile device to answer the questionnaires

Sponsors & Collaborators

• University of Jyvaskyla: lead
• University of Southern Denmark: collaborator
• University of Oulu: collaborator
• University of Helsinki: collaborator
• Tampere University: collaborator
• University of Limerick: collaborator

MeSH Terms

Conditions

Osteoarthritis, Hip; Osteoarthritis

Interventions

Papaverine

Condition Hierarchy (Ancestors)

Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases

Intervention Hierarchy (Ancestors)

Benzylisoquinolines; Alkaloids; Heterocyclic Compounds; Opiate Alkaloids; Isoquinolines; Heterocyclic Compounds, 2-Ring; Heterocyclic Compounds, Fused-Ring

Central Study Contacts

Riikka T Holopainen, PhD

CONTACT

+358401696566; riikka.holopainen@movedoc.fi

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 10 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Visiting researcher

Study Record Dates

• First Submitted: March 3, 2025
• First Posted: April 1, 2025
• Study Start: April 1, 2025
• Primary Completion (Estimated): January 1, 2027
• Study Completion (Estimated): December 1, 2035
• Last Updated: April 3, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will not share